Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pacheco

Showing results (561-570 of 574) with videos related to

Pageof 58
Sort By:
The Lancet. Oncology|March 28, 2024
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trialEgbert F Smit, Enriqueta Felip, Dipesh Uprety, et al.
The New England Journal of Medicine|September 17, 2021
Trastuzumab Deruxtecan in <i>HER2</i>-Mutant Non-Small-Cell Lung CancerBob T Li, Egbert F Smit, Yasushi Goto, et al.
Pediatric Blood & Cancer|December 31, 2013
Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experienceM Navarrete, E Rossi, E Brivio, et al.
Public Health in Practice (Oxford, England)|March 2, 2026
Mobilizing community assets to address health equity: Evaluation of the Communities Organizing to Promote Equity (COPE) project in KansasKristina M Bridges, Sharon Fitzgerald Wolff, Sarah Finocchario-Kessler, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia|June 9, 2021
Antinociceptive and anti-inflammatory activities of Hymenaea martiana Hayne (Fabaceae) in miceA G M Pacheco, E J Pacheco, L A R O Macedo, et al.
Revista De Neurologia|June 12, 2023
[Family planning in men and women with multiple sclerosis. Analysis of the Andalusian Registry (2018-2022)]D Vidal-de Francisco, C Rosa-Garrido, M Ruiz-de Arcos, et al.
JNCI Cancer Spectrum|January 9, 2025
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013Amy C Degnim, Karthik Ghosh, Robert A Vierkant, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 2, 2026
Workplace difficulties in early-stage relapsing-remitting multiple sclerosis with low physical disabilityÁngel Pérez-Sempere, Elena García-Arcelay, Jacobo Caruncho, et al.
The New England Journal of Medicine|June 3, 2022
Adagrasib in Non-Small-Cell Lung Cancer Harboring a <i>KRAS</i> MutationPasi A Jänne, Gregory J Riely, Shirish M Gadgeel, et al.
International Journal of Cardiology. Heart & Vasculature|February 24, 2022
The shifting care and outcomes for patients with endangered limbs - Critical limb ischemia (SCOPE-CLI) registry overview of study design and rationaleLindsey E Scierka, Carlos Mena-Hurtado, Mehdi H Shishehbor, et al.
Pageof 58

Showing results (561-570 of 574) with videos related to

Sort By:
Pageof 58
The Lancet. Oncology|March 28, 2024
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trialEgbert F Smit, Enriqueta Felip, Dipesh Uprety, et al.
The New England Journal of Medicine|September 17, 2021
Trastuzumab Deruxtecan in <i>HER2</i>-Mutant Non-Small-Cell Lung CancerBob T Li, Egbert F Smit, Yasushi Goto, et al.
Pediatric Blood & Cancer|December 31, 2013
Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experienceM Navarrete, E Rossi, E Brivio, et al.
Public Health in Practice (Oxford, England)|March 2, 2026
Mobilizing community assets to address health equity: Evaluation of the Communities Organizing to Promote Equity (COPE) project in KansasKristina M Bridges, Sharon Fitzgerald Wolff, Sarah Finocchario-Kessler, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia|June 9, 2021
Antinociceptive and anti-inflammatory activities of Hymenaea martiana Hayne (Fabaceae) in miceA G M Pacheco, E J Pacheco, L A R O Macedo, et al.
Revista De Neurologia|June 12, 2023
[Family planning in men and women with multiple sclerosis. Analysis of the Andalusian Registry (2018-2022)]D Vidal-de Francisco, C Rosa-Garrido, M Ruiz-de Arcos, et al.
JNCI Cancer Spectrum|January 9, 2025
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013Amy C Degnim, Karthik Ghosh, Robert A Vierkant, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 2, 2026
Workplace difficulties in early-stage relapsing-remitting multiple sclerosis with low physical disabilityÁngel Pérez-Sempere, Elena García-Arcelay, Jacobo Caruncho, et al.
The New England Journal of Medicine|June 3, 2022
Adagrasib in Non-Small-Cell Lung Cancer Harboring a <i>KRAS</i> MutationPasi A Jänne, Gregory J Riely, Shirish M Gadgeel, et al.
International Journal of Cardiology. Heart & Vasculature|February 24, 2022
The shifting care and outcomes for patients with endangered limbs - Critical limb ischemia (SCOPE-CLI) registry overview of study design and rationaleLindsey E Scierka, Carlos Mena-Hurtado, Mehdi H Shishehbor, et al.
Pageof 58